Dana-Farber Cancer Institute | September 23, 2023

Dana-Farber Cancer Institute

Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with cancer the best treatments available today, while leading the research to advance the understanding, diagnosis, treatment, cure and prevention of cancer and related diseases. Located in Boston, Massachusetts, Dana-Farber is a Comprehensive Cancer Center as designated by the National Cancer Institute and an affiliate of the Harvard Medical School.

This symposium is an opportunity for patients and caregivers to learn about melanoma from medical professionals and fellow patients, caregivers, and survivors. This event is FREE and open to all and will be presented in-person and virtually.

Date: Saturday – September 23, 2023

Location: Dana-Farber Cancer Institute, Dana Building, Floor 16, Room 1620, 450 Brookline Avenue, Boston, MA 02215

Presenters & Topics

Welcome
Elizabeth Buchbinder, MD, Medical Oncologist, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School

 

Neoadjuvant Therapy and Adjuvant Therapy (Pre- and
Post-Surgery) for Melanoma
Meghan J. Mooradian, MD
Clinical Oncologist, Massachusetts General Hospital
Assistant Professor of Medicine Harvard Medical School

 

Surgery for Melanoma
Sonia Cohen, MD, PhD
Melanoma and Sarcoma Surgical Oncology
Massachusetts General Hospital

 

Vaccine Therapy
Patrick Ott, MD, PhD
Clinical Director, Melanoma Disease Center
Director, Clinical Sciences, Center for Immuno-Oncology,
Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School

 

Bispecific Therapies and Other Novel Immunotherapies
Ryan J. Sullivan, MD
Associate Professor, Harvard Medical School
Hematology/Oncology
Massachusetts General Hospital

 

TIL Cancer Therapy: Revolutionizing Cancer Treatment with Immune Power
Elizabeth Buchbinder, MD, Medical Oncologist, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School

 

Closing Remarks and AIM at Melanoma Patient
Resources
Ann Garst Taylor
Director of Community Engagement,
AIM at Melanoma Foundation